Benzimidazole-derivatives as factor Xa inhibitors

Details for Australian Patent Application No. 2004238497 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Ritter, Kurt; Wagner, Michael; Matter, Hans; Urmann, Matthias; Wehner, Volkmar; Nazare, Marc

Agent Watermark

Pub. Number AU-B-2004238497

PCT Pub. Number WO2004/101553

Priority 03011305.4 19.05.03 EP

Filing date 5 May 2004

Wipo publication date 25 November 2004

Acceptance publication date 22 July 2010

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 235/24 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 473/08 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/101553 Priority application(s): WO2004/101553

22 July 2010 Application Accepted

  Published as AU-B-2004238497

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238498-Triazole-derivatives as factor Xa inhibitors

2004238496-Bottle seal